The profibrogenic effects of TNF-α in another fibrosis model, which uses CCl4, have been reported previously, indicating that TNFR1 deficiency inhibits liver fibrosis after CCl4 treatment, without any effects on liver injury [10], [38]. This evidence concerns the gene TNFRSF1A and Hepatic fibrosis.